
Interstitial lung diseases (ILDs) remain among the most challenging conditions in respiratory medicine, marked by clinical heterogeneity, progressive decline, and outcomes that rival advanced malignancy. Over the past decade, advances in diagnostics, therapeutics, and multidisciplinary...